# A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

> **NCT04975035** · PHASE1,PHASE2 · TERMINATED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 200 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Zolodine

## Key facts

- **NCT ID:** NCT04975035
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01-01
- **Primary completion:** 2012-07-01
- **Final completion:** 2012-07-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975035, "A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04975035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*